Table 2.
Aptamers that have been identified to breast cancer.
| Target | Aptamer | Name | Reference |
|---|---|---|---|
| HER2 protein | DNA | HeA2_1, HeA2_3 | [65] |
| HER2 protein | RNA | SE15-8 | [66] |
| Extra-cellular domain (ECD) of HER2protein | DNA | ECD_Apt1 | [67] |
| Epitope peptide of HER2 | DNA | HB5 | [68] |
| HER2 extracellular domain | DNA | Heraptamer1, Heraptamer2 | [69] |
| HER2 protein | RNA | TSA14 | [70] |
| HER2 peptide | DNA | HY6 | [71] |
| ERα | DNA | ERaptD4 | [72] |
| Cell surface associated (MUC1) protein | DNA | S2.2 | [9] |
| Five MUC1 tandem repeats (MUC1-5TR) | DNA | 5TR1 | [73] |
| A peptide epitope of MUC1 | DNA | MA3 | [74] |
| Receptor-binding domain (RBD) of VEGF | DNA | Vap7 | [75] |
| Periostin | DNA | PNDA-3 | [76] |
| SK-BR-3 cell line | RNA | S6 | [77] |
| MCF-10AT1 cell line | DNA | KMF2-1a | [78] |
| MCF-7 cell line | DNA | MS03 | [79] |
| N202.1A cell line | RNA | C1,E1 | [80] |
| MDA-MB-231 cell line | DNA | LXL-1 | [81] |
| Breast cancer tissue | DNA | BC15 | [52] |